Farmaforum 2024

26 Sept 2024 | Madrid, Spain

ServiceUpdated on 2 September 2024

Bioanalysis of Small Molecules & Generics

Xavier Martínez

Business Developer at KYMOS, S.L.U.

Barcelona, Barcelona, Spain

About

We are a GLP-certified and GCP compliant multinational CRO with broad experience working with large generics companies in need of full bioequivalence studies and small biotech innovators carrying out basic R&D. We also work with animal health firms to carry out residue depletion studies. Our experienced bioanalysis of small molecules team can support you in these specialist areas:

• Preclinical studies of small molecules
• PK (pharmacokinetics) and PD (pharmacodynamic) calculations and statistics
• Metabolite identification and quantification
• Toxicokinetics
• Biomarkers/Pharmacodynamics
• Clinical studies of small molecules
• Phase I-IV pharmacokinetics including first-in-man dose escalation studies
• Drug-drug interaction studies
• Biomarkers/Pharmacodynamics
• Bioequivalence studies of generics
• Percutaneous absorption
• Residue depletion studies
• Absorption studies

Similar opportunities

  • Service

    Leon Research

    Beatriz Caballero Sanchez

    International Business Development at León Research

    Leon, Leon, Spain

  • Project cooperation

    Enzyme Immobilization & Stabilization. Biomed Applications

    Fernando Casal

    Knowledge Transfer & International Projects at CiQUS - Center for Research in Biological Chemistry and Molecular Materials

    Santiago de Compostela, Spain

  • Product

    BIPHOTONE MARKERS OF MITOCHONDRIA

    • Other
    • Digital health
    • Health innovation
    • Laboratory industry
    • Pharmaceutical industry

    Ana Somé

    Technology Transfer Manager - Specialist on Intellectual Property at Universidad de Málaga

    Málaga, Spain